Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Other Working Capital Changes (2020 - 2025)

PROCEPT BioRobotics has reported Other Working Capital Changes over the past 6 years, most recently at $2.2 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $2.2 million for Q4 2025, up 638.87% from a year ago — trailing twelve months through Dec 2025 was $2.9 million (up 11.52% YoY), and the annual figure for FY2025 was $2.9 million, up 11.52%.
  • Other Working Capital Changes for Q4 2025 was $2.2 million at PROCEPT BioRobotics, up from $448000.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for PRCT hit a ceiling of $7.4 million in Q3 2023 and a floor of -$6.0 million in Q4 2023.
  • Median Other Working Capital Changes over the past 5 years was $271000.0 (2024), compared with a mean of $497277.8.
  • Peak annual rise in Other Working Capital Changes hit 3575.25% in 2023, while the deepest fall reached 1475.71% in 2023.
  • PROCEPT BioRobotics' Other Working Capital Changes stood at $2.0 million in 2021, then dropped by 16.77% to $1.7 million in 2022, then plummeted by 459.95% to -$6.0 million in 2023, then surged by 104.98% to $301000.0 in 2024, then skyrocketed by 638.87% to $2.2 million in 2025.
  • The last three reported values for Other Working Capital Changes were $2.2 million (Q4 2025), $448000.0 (Q3 2025), and $223000.0 (Q2 2025) per Business Quant data.